Skip to content
Lactose logo

Lactose

524202 BSE
₹106.40 down 0.60 (0.56%)
Market Cap
₹134 Cr
P/E
19.31

Lactose (LACTOSE) share price was ₹107.00 at the 28 Oct 2026 close; market capitalisation ₹135 Cr; P/E (TTM) 19.42; sector Healthcare. The share price fell 6.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 18.7% year on year to ₹46.97 Cr and net profit was ₹2.37 Cr, against ₹1.50 Cr a year earlier (compared with Jun 2025). Promoters held 53.65% of Lactose in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 52/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹107.00 −8.50 −7.36% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹134 Cr
P/E (TTM)
19.31
EBITDA
₹19.40 Cr
Return on Equity
9.36%
Debt to Equity
0.95
Book Value
₹46.28
EPS (TTM)
₹5.51
52W High
₹136.45
52W Low
₹76.01

Price-based figures as of 29 Oct 2026, 10:28 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,763.6034.994,23,147 Cr5.060.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,664.0087.712,56,549 Cr15.310.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,588.3072.031,74,524 Cr9.500.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,195.10108.451,18,604 Cr22.380.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,183.9026.341,18,094 Cr4.360.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,365.7032.721,10,329 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Lactose (this company)
₹106.4019.31134 Cr2.300.00%9.36%14.67%172 Cr7 Cr
Median 8 companies₹1,564.6534.831,18,349 Cr4.710.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

52 Average
Overall score

Data confidence 100/100

Category scores

Quality Average 50
Returns, margins, earnings quality 22% weight
Valuation Average 51
Cheap vs sector & own history 24% weight
Growth Strong 82
Sales & profit trajectory 9% weight
Financial Health Poor 26
Solvency, leverage, coverage 9% weight
Momentum Good 56
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 34.8% CAGR over last 5 years
  • Company's working capital requirements have reduced from 22.6 days to 18.1 days

Weaknesses

3
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 11.3% over last 3 years.
  • Promoters have pledged 26.1% of their holding.

Technical Indicators

Oscillators

Bullish

Bearish
1
Neutral
6
Bullish
2

Overall

Bullish

Bearish
1
Neutral
6
Bullish
12

Moving Averages

Bullish

Bearish
0
Neutral
0
Bullish
10

Growth Rate

Revenue Growth
39.44% higher than 3Y

change over 1 year

Net Income Growth
17.31% lower than 3Y

change over 1 year

Cash Flow Change
—

EBITDA Margin Change
-24.26%

change over 1 year Operating margin 12.92% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
27.47
24.43
32.6
29.4
29.46
30.45
28.72
27.77
39.58
41.18
36.77
45.77
46.97
Expenses
23.7
21.04
26.88
23.28
23.88
25.44
25.75
24.36
35.11
35.92
33.71
40.75
40.9
Operating Profit
3.77
3.39
5.72
6.12
5.58
5.01
2.97
3.41
4.47
5.26
3.06
5.02
6.07
OPM %
13.72%
13.88%
17.55%
20.82%
18.94%
16.45%
10.34%
12.28%
11.29%
12.77%
8.32%
10.97%
12.92%
Other Income
0.28
0.26
0.28
0.31
0.22
0.3
0.56
0.37
0.41
0.37
0.63
0.22
0.56
Interest
1.55
1.31
1.21
1.17
1.26
1.37
1.64
1.84
1.22
1.04
1.39
1.43
1.76
Depreciation
1.19
1.2
1.2
1.63
1.31
1.33
1.35
1.39
1.37
1.44
1.43
1.5
1.64
PBT
1.31
1.14
3.59
3.63
3.23
2.61
0.54
0.55
2.29
3.15
0.87
2.31
3.23
Tax %
26.72%
28.95%
27.02%
33.88%
29.72%
22.22%
59.26%
-18.18%
34.5%
31.11%
40.23%
18.61%
26.93%
Net Profit
0.96
0.81
2.63
2.4
2.27
2.03
0.22
0.64
1.5
2.16
0.53
1.88
2.37
EPS (₹)
0.76
0.64
2.09
1.91
1.8
1.61
0.17
0.51
1.19
1.72
0.42
1.49
1.88
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
24
34
36
31
41
40
35
46
66
114
116
163
171
Expenses
19
24
24
25
31
31
29
34
54
95
99
145
151
Operating Profit
5
10
11
6
10
9
6
12
11
19
17
18
19
OPM %
22%
30%
32%
18%
24%
23%
18%
27%
17%
17%
15%
11%
11%
Other Income
0
1
1
1
0
0
0
1
1
1
1
1
2
Interest
3
4
4
5
5
6
5
5
6
5
6
5
6
Depreciation
2
3
3
4
4
4
4
5
5
5
5
6
6
PBT
1
4
4
-3
1
0
-3
3
1
10
7
9
10
Tax %
42%
28%
36%
-52%
33%
30%
-24%
23%
18%
30%
25%
30%
—
Net Profit
0
3
3
-1
1
0
-2
2
1
7
5
6
7
EPS (₹)
0.59
3.17
2.87
-1.32
0.71
0.07
-2.17
1.95
0.96
5.39
4.1
4.81
5.51
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
9
10
10
10
10
11
13
13
13
13
13
Reserves
7
12
17
22
24
24
24
27
28
35
46
52
Borrowings
39
37
34
38
36
39
46
41
38
39
57
62
Other Liabilities
25
26
24
13
11
10
7
10
22
14
18
56
Total Liabilities
80
83
85
83
82
84
88
90
101
101
133
183
Fixed Assets
62
61
64
63
60
62
59
59
56
55
52
69
CWIP
1
1
1
0
1
0
4
0
0
0
10
0
Investments
1
0
0
0
0
0
1
1
0
0
0
0
Other Assets
15
21
20
19
20
22
25
30
45
46
71
114
Total Assets
80
83
85
83
82
84
88
90
101
101
133
183
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
13
1
8
0
5
7
2
8
8
9
0
6
Investing
-23
3
-5
-2
-2
-3
-6
-1
-1
-2
-16
-10
Financing
10
-5
-3
4
-5
-4
5
-8
-8
-6
19
1
Net Cash Flow
-1
0
0
3
-2
1
1
0
-1
1
3
-4
Free Cash Flow
-10
0
3
-2
3
4
-3
7
6
7
-14
-5
CFO/OP
255
18
74
15
58
80
34
68
70
50
5
37
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
83
96
91
63
62
64
67
90
69
49
68
75
Inventory Days
129
344
440
456
384
471
587
343
344
119
171
217
Days Payable
273
340
559
330
242
202
153
195
275
59
74
146
Cash Conversion Cycle
-61
100
-27
188
204
333
501
238
138
109
165
146
Working Capital Days
-118
-100
-107
18
42
59
56
46
56
26
24
18
ROCE %
8%
13%
15%
4%
9%
8%
3%
10%
9%
18%
13%
11%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Lactose insights

64 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

DIIs0.62%Promot.53.65%Others7.12%Public38.62%As ofSep 2026
26.07% of promoter holding pledged as of 14 Oct 2026

Documents

1
Concall - Feb 2026 Feb 2026
2
Concall - Nov 2025 Nov 2025
3
Concall - Aug 2025 Aug 2025
4
Concall - May 2025 May 2025
5
Concall - Feb 2025 Feb 2025

Frequently Asked Questions about Lactose

What does Lactose (India) Ltd do?
Incorporated in 1991, Lactose (India) Ltd manufactures Pharmaceutical Products and carries out job work[1]
Where is Lactose (India) Ltd (LACTOSE) listed?
Lactose (India) Ltd trades under code 524202 on the BSE.
Which sector does Lactose (India) Ltd belong to?
Lactose (India) Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Lactose (India) Ltd?
Lactose (India) Ltd has a market capitalisation of ₹134 Cr as of 29 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Lactose (India) Ltd?
Lactose (India) Ltd trades at a PE ratio of 19.31 as of 29 Oct 2026, on earnings per share of ₹5.51, against a book value of ₹46.28 per share.
What is the 52-week high and low of Lactose (India) Ltd?
Over the last 52 weeks Lactose (India) Ltd has traded between ₹76.01 and ₹136.45 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Lactose (India) Ltd?
Lactose (India) Ltd reported a return on equity of 9.36%. Its debt-to-equity ratio is 0.95.

Company Information

Incorporated in 1991, Lactose (India) Ltd manufactures Pharmaceutical Products and carries out job work[1]

Website lactoseindialimited.com
Face Value ₹ 10
Shares Outstanding 1,25,94,003

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524202.md for Lactose (India) Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month